US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Psyence Biomedical Ltd

4.33

+0.400010.18%

Post-market: 4.29-0.0400-0.92%19:49 EDT

Volume:103.30K

Turnover:433.89K

Market Cap:16.52M

PE:-0.34

High:4.49

Open:4.00

Low:3.91

Close:3.93

52wk High:34.63

52wk Low:1.92

Shares:3.81M

Float Shares:1.09M

Volume Ratio:0.42

T/O Rate:9.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-12.5596

EPS(LYR):32.76

ROE:-58.62%

ROA:-31.33%

PB:0.97

PE(LYR):0.13

Loading ...

Overview Company News Filings

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:06 PM

Top Midday Gainers

MT Newswires Live

Psyence BioMed welcomes planned US executive order to evaluate ibogaine research

Why Is Psyence Biomedical Stock (PBM) Up Today?

Top Premarket Gainers

MT Newswires Live

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:50 AM

Psyence Biomedical Ltd - Expands Australian Clinical Site Network to Five Sites

THOMSON REUTERS

Psyence BioMed expands Australia clinical trial network to five sites for NPX-5 program

A Look At Cigna Group’s Valuation After PBM Reform Progress And New CEO Announcement

Simply Wall St.

Mochi Finance founder offloads 550K CVX as fraud claims deepen across DeFi

Psyence Group; GoldCoast private placement raises $2.78 million on $0.85 shares

Should FTC Insulin Settlement And PBM Lawsuit Shift How Investors View CVS Health’s (CVS) Risk-Reward Profile?

Simply Wall St.

Psyence Group says GoldCoast raises CAD 5.83 million in financing tied to proposed amalgamation

Psyence BioMed Plans to Advance Vertically Integrated Platform and Product and Clinical Development Program, Targeting Phase IIb Trial Execution and Regulatory Readiness

Psyence Biomedical appoints Sashank Pillay to board after Seth Feuerstein resigns

Corporate Update: Psyence Biomed Advances Vertically Integrated Pharmaceutical Platform Following Psylabs Export Milestone

THOMSON REUTERS

BRIEF-Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical Trial

Psyence Biomed Announces Export of Gmp-Manufactured Natural Psilocybin (Npx-5) to Australia for Ongoing Phase Iib Clinical Trial

THOMSON REUTERS

Psyence Biomedical Names Sashank Pillay to Board After Seth Feuerstein Resigns

Psyence extends GoldCoast amalgamation deadline to May 31, 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PBM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","market":"US","secType":"STK","nameCN":"Psyence Biomedical Ltd","latestPrice":4.33,"timestamp":1787342400000,"preClose":3.93,"halted":0,"volume":103302,"hourTrading":{"tag":"盘后","latestPrice":4.29,"preClose":4.33,"latestTime":"19:49 EDT","volume":2963,"amount":12635.6522,"timestamp":1787356190739,"change":-0.04,"changeRate":-0.009238,"amplitude":0.030023},"delay":0,"changeRate":0.10178117048346054,"floatShares":1094600,"shares":3814300,"eps":-12.559563,"marketStatus":"Market Closed","change":0.4,"latestTime":"08-21 16:00:00 EDT","open":4,"high":4.49,"low":3.914,"amount":433891.88054459996,"amplitude":0.146565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-12.559563,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.93,"preHourTrading":{"tag":"盘前","latestPrice":3.92,"preClose":3.93,"latestTime":"09:09 EDT","volume":573,"amount":2306.1608355,"timestamp":1787317781274,"change":-0.01,"changeRate":-0.002545,"amplitude":0.030534},"postHourTrading":{"tag":"盘后","latestPrice":4.29,"preClose":4.33,"latestTime":"19:49 EDT","volume":2963,"amount":12635.6522,"timestamp":1787356190739,"change":-0.04,"changeRate":-0.009238,"amplitude":0.030023},"volumeRatio":0.4219053892847846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBM\",,,,,undefined,":{"symbol":"PBM","floatShares":1094600,"roa":"-31.33%","roe":"-58.62%","lyrEps":32.757919,"volumeRatio":0.4219053892847846,"shares":3814300,"dividePrice":0,"high":4.49,"amplitude":0.146565,"preClose":3.93,"low":3.914,"week52Low":1.92,"pbRate":"0.97","week52High":34.625,"institutionHeld":0.0125,"latestPrice":4.33,"eps":-12.559563,"divideRate":0,"volume":103302,"delay":0,"ttmEps":-12.559563,"open":4,"prevYearClose":4.7088,"prevWeekClose":3.48,"prevMonthClose":3.17,"prevQuarterClose":3.06,"fiveDayClose":3.48,"twentyDayClose":2.95,"sixtyDayClose":4.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-02","symbol":"PBM","defaultRemindTime":1770042600000,"type":"split","dateTimestamp":1770008400000,"forFactor":625,"toFactor":100,"ratio":6.25},{"market":"US","date":"2025-05-05","symbol":"PBM","defaultRemindTime":1746451800000,"type":"split","dateTimestamp":1746417600000,"forFactor":797,"toFactor":100,"ratio":7.97},{"market":"US","date":"2024-11-26","symbol":"PBM","defaultRemindTime":1732631400000,"type":"split","dateTimestamp":1732597200000,"forFactor":75,"toFactor":1,"ratio":75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBM","date":"2026-08-21","current":-0.344757,"percent":0.191523,"low":-8.987173,"twenty":-2.088818,"median":-0.171634,"eighty":-0.034281,"high":43.62106,"avg":0.034688,"sd":5.42689,"marketCap":14990309},"quantilePoints":[{"date":"2024-02-09","current":-4.032357,"twenty":-6.238869,"median":-6.072412,"eighty":-4.789887,"marketCap":12687649},{"date":"2024-02-16","current":-2.839339,"twenty":-6.098548,"median":-3.798256,"eighty":-3.119893,"marketCap":8908805},{"date":"2024-02-23","current":-2.317077,"twenty":-5.416526,"median":-3.308726,"eighty":-2.830575,"marketCap":7275145},{"date":"2024-03-01","current":-2.358335,"twenty":-4.411122,"median":-2.857169,"eighty":-2.443954,"marketCap":7364862},{"date":"2024-03-08","current":-5.40272,"twenty":-4.595223,"median":-2.890292,"eighty":-2.448252,"marketCap":17006136},{"date":"2024-03-15","current":-6.789855,"twenty":-5.670597,"median":-3.448439,"eighty":-2.49853,"marketCap":21291147},{"date":"2024-03-22","current":-4.959176,"twenty":-5.522615,"median":-3.851628,"eighty":-2.531651,"marketCap":15533164},{"date":"2024-03-28","current":-5.045126,"twenty":-5.473209,"median":-4.390178,"eighty":-2.58397,"marketCap":15800977},{"date":"2024-04-05","current":-4.43423,"twenty":-5.384879,"median":-4.562142,"eighty":-2.723572,"marketCap":13926285},{"date":"2024-04-12","current":-3.616183,"twenty":-5.308825,"median":-4.386712,"eighty":-2.826193,"marketCap":11169148},{"date":"2024-04-19","current":-2.969424,"twenty":-5.158983,"median":-4.227564,"eighty":-2.846471,"marketCap":9153854},{"date":"2024-04-26","current":-3.634228,"twenty":-5.044947,"median":-3.989124,"eighty":-2.883667,"marketCap":11244136},{"date":"2024-05-03","current":-5.498334,"twenty":-5.135216,"median":-4.022166,"eighty":-2.931227,"marketCap":17006136},{"date":"2024-05-10","current":-4.755664,"twenty":-5.044947,"median":-4.198236,"eighty":-2.950931,"marketCap":14729724},{"date":"2024-05-17","current":-3.914422,"twenty":-5.029183,"median":-4.161003,"eighty":-2.965515,"marketCap":12185499},{"date":"2024-05-24","current":-3.576034,"twenty":-4.995271,"median":-3.989124,"eighty":-2.992841,"marketCap":11063362},{"date":"2024-05-31","current":-2.410174,"twenty":-4.97525,"median":-3.912167,"eighty":-2.927321,"marketCap":10042674},{"date":"2024-06-07","current":-2.153089,"twenty":-4.945403,"median":-3.739796,"eighty":-2.692286,"marketCap":8971456},{"date":"2024-06-14","current":-1.939708,"twenty":-4.890182,"median":-3.700097,"eighty":-2.466859,"marketCap":8082344},{"date":"2024-06-21","current":-1.253291,"twenty":-4.889663,"median":-3.668675,"eighty":-2.422386,"marketCap":5222190},{"date":"2024-06-28","current":-0.96407,"twenty":-4.844987,"median":-3.634228,"eighty":-2.361971,"marketCap":4017069},{"date":"2024-07-05","current":-0.935148,"twenty":-4.815866,"median":-3.576034,"eighty":-2.32332,"marketCap":3896557},{"date":"2024-07-12","current":-0.998455,"twenty":-4.766248,"median":-3.491099,"eighty":-2.088818,"marketCap":4160345},{"date":"2024-07-19","current":-1.323989,"twenty":-4.726555,"median":-3.448439,"eighty":-1.937394,"marketCap":5516775},{"date":"2024-07-26","current":-1.867403,"twenty":-4.683035,"median":-3.197485,"eighty":-1.910851,"marketCap":7781064},{"date":"2024-08-02","current":-0.143956,"twenty":-4.658595,"median":-2.969424,"eighty":-1.31949,"marketCap":7364628},{"date":"2024-08-09","current":-0.138564,"twenty":-4.597134,"median":-2.93318,"eighty":-1.252648,"marketCap":7088789},{"date":"2024-08-16","current":-0.175224,"twenty":-4.56626,"median":-2.839339,"eighty":-1.14223,"marketCap":8964295},{"date":"2024-08-23","current":-0.164846,"twenty":-4.484876,"median":-2.620747,"eighty":-1.025128,"marketCap":8433350},{"date":"2024-08-30","current":-0.133743,"twenty":-4.446042,"median":-2.530201,"eighty":-0.96664,"marketCap":6842183},{"date":"2024-09-06","current":-0.062172,"twenty":-4.437003,"median":-2.444094,"eighty":-0.946331,"marketCap":3180663},{"date":"2024-09-13","current":-0.050913,"twenty":-4.377208,"median":-2.41628,"eighty":-0.171823,"marketCap":2604637},{"date":"2024-09-20","current":-0.039131,"twenty":-4.329259,"median":-2.362614,"eighty":-0.163756,"marketCap":2001897},{"date":"2024-09-27","current":-0.035312,"twenty":-4.305444,"median":-2.355493,"eighty":-0.148457,"marketCap":1806550},{"date":"2024-10-04","current":-0.032669,"twenty":-4.254131,"median":-2.317077,"eighty":-0.14305,"marketCap":1671309},{"date":"2024-10-11","current":-0.031494,"twenty":-4.19237,"median":-2.120953,"eighty":-0.135288,"marketCap":1611202},{"date":"2024-10-18","current":-0.035247,"twenty":-4.164165,"median":-2.088818,"eighty":-0.127633,"marketCap":1803210},{"date":"2024-10-25","current":-0.031592,"twenty":-4.083815,"median":-1.933924,"eighty":-0.075611,"marketCap":1616211},{"date":"2024-11-01","current":-0.02265,"twenty":-4.026242,"median":-1.927818,"eighty":-0.057485,"marketCap":1158729},{"date":"2024-11-08","current":-0.024869,"twenty":-3.982516,"median":-1.638758,"eighty":-0.044294,"marketCap":1272265},{"date":"2024-11-15","current":-0.049784,"twenty":-3.931086,"median":-1.323989,"eighty":-0.044294,"marketCap":2546883},{"date":"2024-11-22","current":-0.042798,"twenty":-3.911717,"median":-1.256183,"eighty":-0.044338,"marketCap":2189514},{"date":"2024-11-29","current":-0.045389,"twenty":-3.854339,"median":-1.251684,"eighty":-0.044435,"marketCap":2322054},{"date":"2024-12-06","current":-0.046144,"twenty":-3.758505,"median":-1.181949,"eighty":-0.045374,"marketCap":2360678},{"date":"2024-12-13","current":-0.036019,"twenty":-3.736446,"median":-1.098558,"eighty":-0.042081,"marketCap":1842723},{"date":"2024-12-20","current":-0.213027,"twenty":-3.720507,"median":-1.025128,"eighty":-0.041056,"marketCap":10898254},{"date":"2024-12-27","current":-0.195572,"twenty":-3.702521,"median":-0.998455,"eighty":-0.041494,"marketCap":10005291},{"date":"2025-01-03","current":-0.174804,"twenty":-3.696057,"median":-0.967283,"eighty":-0.041676,"marketCap":8942782},{"date":"2025-01-10","current":-0.147112,"twenty":-3.67593,"median":-0.957643,"eighty":-0.042486,"marketCap":7526104},{"date":"2025-01-17","current":-0.1549,"twenty":-3.667341,"median":-0.574087,"eighty":-0.042776,"marketCap":7924545},{"date":"2025-01-24","current":-0.172934,"twenty":-3.665023,"median":-0.208553,"eighty":-0.043408,"marketCap":8057358},{"date":"2025-01-31","current":-0.14918,"twenty":-3.646165,"median":-0.184323,"eighty":-0.044744,"marketCap":6950578},{"date":"2025-02-07","current":-0.129701,"twenty":-3.623401,"median":-0.178377,"eighty":-0.045379,"marketCap":6043019},{"date":"2025-02-14","current":-0.132551,"twenty":-3.592094,"median":-0.174804,"eighty":-0.045783,"marketCap":6175832},{"date":"2025-02-21","current":-0.123525,"twenty":-3.571282,"median":-0.172934,"eighty":-0.046085,"marketCap":5755256},{"date":"2025-02-28","current":-0.117823,"twenty":-3.543472,"median":-0.170272,"eighty":-0.046183,"marketCap":5489629},{"date":"2025-03-07","current":-0.087417,"twenty":-3.495369,"median":-0.16615,"eighty":-0.046596,"marketCap":4072950},{"date":"2025-03-14","current":-0.074485,"twenty":-3.463351,"median":-0.163664,"eighty":-0.047435,"marketCap":3470419},{"date":"2025-03-21","current":-0.059349,"twenty":-3.451625,"median":-0.159632,"eighty":-0.048363,"marketCap":2765179},{"date":"2025-03-28","current":-0.05971,"twenty":-3.386977,"median":-0.158361,"eighty":-0.049116,"marketCap":2782002},{"date":"2025-04-04","current":-0.04489,"twenty":-3.267253,"median":-0.1549,"eighty":-0.049116,"marketCap":2091532},{"date":"2025-04-11","current":-0.043618,"twenty":-3.203179,"median":-0.154152,"eighty":-0.046323,"marketCap":2032227},{"date":"2025-04-17","current":-0.042568,"twenty":-3.140804,"median":-0.151236,"eighty":-0.046065,"marketCap":1983334},{"date":"2025-04-25","current":-0.053422,"twenty":-3.016258,"median":-0.148843,"eighty":-0.045369,"marketCap":2489014},{"date":"2025-05-02","current":-0.04217,"twenty":-2.968121,"median":-0.146958,"eighty":-0.044944,"marketCap":1964773},{"date":"2025-05-09","current":-0.047195,"twenty":-2.958916,"median":-0.143956,"eighty":-0.045202,"marketCap":2198901},{"date":"2025-05-16","current":-0.065096,"twenty":-2.939039,"median":-0.143033,"eighty":-0.045369,"marketCap":3032967},{"date":"2025-05-23","current":-0.055332,"twenty":-2.910166,"median":-0.139192,"eighty":-0.045482,"marketCap":2578022},{"date":"2025-05-30","current":-0.065345,"twenty":-2.857169,"median":-0.138564,"eighty":-0.045852,"marketCap":3044574},{"date":"2025-06-06","current":-0.063844,"twenty":-2.839339,"median":-0.135018,"eighty":-0.046045,"marketCap":2974641},{"date":"2025-06-13","current":-0.058023,"twenty":-2.817429,"median":-0.132806,"eighty":-0.046068,"marketCap":2703424},{"date":"2025-06-20","current":-0.061591,"twenty":-2.692286,"median":-0.131126,"eighty":-0.046129,"marketCap":2869653},{"date":"2025-06-27","current":26.979573,"twenty":-2.596595,"median":-0.130176,"eighty":-0.046129,"marketCap":27297662},{"date":"2025-07-03","current":27.487604,"twenty":-2.551768,"median":-0.129464,"eighty":-0.045667,"marketCap":27811683},{"date":"2025-07-11","current":26.19376,"twenty":-2.531167,"median":-0.127325,"eighty":-0.04489,"marketCap":26502584},{"date":"2025-07-18","current":27.61963,"twenty":-2.482695,"median":-0.125116,"eighty":-0.043883,"marketCap":27945265},{"date":"2025-07-25","current":5.7589,"twenty":-2.446866,"median":-0.121624,"eighty":-0.042776,"marketCap":5826797},{"date":"2025-08-01","current":2.899625,"twenty":-2.443883,"median":-0.117823,"eighty":-0.042564,"marketCap":2933812},{"date":"2025-08-08","current":2.409629,"twenty":-2.430929,"median":-0.116873,"eighty":-0.041187,"marketCap":2438039},{"date":"2025-08-15","current":1.931163,"twenty":-2.415059,"median":-0.115922,"eighty":-0.040303,"marketCap":1953931},{"date":"2025-08-22","current":1.844692,"twenty":-2.395713,"median":-0.095437,"eighty":-0.03915,"marketCap":1866441},{"date":"2025-08-29","current":1.712105,"twenty":-2.371998,"median":-0.086044,"eighty":-0.036019,"marketCap":1732291},{"date":"2025-09-05","current":1.487283,"twenty":-2.362357,"median":-0.084153,"eighty":-0.035684,"marketCap":1504818},{"date":"2025-09-12","current":1.867751,"twenty":-2.360517,"median":-0.075977,"eighty":-0.035051,"marketCap":1889772},{"date":"2025-09-19","current":3.055271,"twenty":-2.356062,"median":-0.074774,"eighty":-0.033798,"marketCap":3091293},{"date":"2025-09-26","current":1.769752,"twenty":-2.341544,"median":-0.069101,"eighty":-0.031722,"marketCap":1790617},{"date":"2025-10-03","current":1.896574,"twenty":-2.321759,"median":-0.068517,"eighty":-0.030678,"marketCap":1918935},{"date":"2025-10-10","current":2.132926,"twenty":-2.285546,"median":-0.066599,"eighty":-0.029539,"marketCap":2158073},{"date":"2025-10-17","current":1.988809,"twenty":-2.204185,"median":-0.065502,"eighty":-0.025065,"marketCap":2012257},{"date":"2025-10-24","current":1.922516,"twenty":-2.127381,"median":-0.065096,"eighty":-0.022271,"marketCap":1945182},{"date":"2025-10-31","current":1.80434,"twenty":-2.088818,"median":-0.063691,"eighty":1.436554,"marketCap":1825613},{"date":"2025-11-07","current":1.448659,"twenty":-2.088818,"median":-0.062888,"eighty":1.555882,"marketCap":1465739},{"date":"2025-11-14","current":1.608341,"twenty":-2.06311,"median":-0.062194,"eighty":1.555882,"marketCap":1627303},{"date":"2025-11-21","current":3.182406,"twenty":-1.990611,"median":-0.061648,"eighty":1.615259,"marketCap":3219927},{"date":"2025-11-28","current":-0.729044,"twenty":-1.937394,"median":-0.062172,"eighty":1.602576,"marketCap":2873598},{"date":"2025-12-05","current":-0.859655,"twenty":-1.92814,"median":-0.062562,"eighty":1.576058,"marketCap":3388412},{"date":"2025-12-12","current":-0.736168,"twenty":-1.928076,"median":-0.063663,"eighty":1.561647,"marketCap":2901679},{"date":"2025-12-19","current":-0.693423,"twenty":-1.926597,"median":-0.06447,"eighty":1.557612,"marketCap":2733194},{"date":"2025-12-26","current":-0.422703,"twenty":-1.921713,"median":-0.065346,"eighty":1.550694,"marketCap":1666125},{"date":"2026-01-02","current":-0.357825,"twenty":-1.878265,"median":-0.066038,"eighty":1.541471,"marketCap":1410403},{"date":"2026-01-09","current":-0.364854,"twenty":-1.501571,"median":-0.067537,"eighty":1.529941,"marketCap":1438109},{"date":"2026-01-16","current":-1.086109,"twenty":-1.384919,"median":-0.068687,"eighty":1.495353,"marketCap":4281003},{"date":"2026-01-23","current":-1.232306,"twenty":-1.345841,"median":-0.070643,"eighty":1.476907,"marketCap":4857255},{"date":"2026-01-30","current":-1.16796,"twenty":-1.310492,"median":-0.075063,"eighty":1.457191,"marketCap":4603628},{"date":"2026-02-06","current":-0.749465,"twenty":-1.275272,"median":-0.079702,"eighty":1.433787,"marketCap":2954088},{"date":"2026-02-13","current":-0.728718,"twenty":-1.255862,"median":-0.084567,"eighty":1.385825,"marketCap":2872314},{"date":"2026-02-20","current":-0.678434,"twenty":-1.254062,"median":-0.086562,"eighty":1.348931,"marketCap":2674114},{"date":"2026-02-27","current":-0.762515,"twenty":-1.252005,"median":-0.096653,"eighty":0.790993,"marketCap":3005527},{"date":"2026-03-06","current":-1.489464,"twenty":-1.256504,"median":-0.11687,"eighty":-0.020561,"marketCap":5870865},{"date":"2026-03-13","current":-1.431282,"twenty":-1.397516,"median":-0.117348,"eighty":-0.02169,"marketCap":5641535},{"date":"2026-03-20","current":-1.367281,"twenty":-1.441754,"median":-0.117823,"eighty":-0.022271,"marketCap":5389271},{"date":"2026-03-27","current":-1.530191,"twenty":-1.441754,"median":-0.121666,"eighty":-0.02261,"marketCap":6031397},{"date":"2026-04-02","current":-1.378917,"twenty":-1.45339,"median":-0.125116,"eighty":-0.023061,"marketCap":5435137},{"date":"2026-04-10","current":-1.454554,"twenty":-1.454554,"median":-0.127325,"eighty":-0.024739,"marketCap":5733267},{"date":"2026-04-17","current":-3.415294,"twenty":-1.470845,"median":-0.129464,"eighty":-0.024967,"marketCap":13461712},{"date":"2026-04-24","current":-5.253851,"twenty":-1.489464,"median":-0.130176,"eighty":-0.025978,"marketCap":20708562},{"date":"2026-05-01","current":-3.834206,"twenty":-1.539501,"median":-0.132679,"eighty":-0.028616,"marketCap":15112893},{"date":"2026-05-08","current":-3.502567,"twenty":-1.708229,"median":-0.134927,"eighty":-0.029268,"marketCap":13805708},{"date":"2026-05-15","current":-2.932382,"twenty":-1.928076,"median":-0.136986,"eighty":-0.029456,"marketCap":11558267},{"date":"2026-05-22","current":-2.362196,"twenty":-2.075964,"median":-0.139192,"eighty":-0.029791,"marketCap":9310826},{"date":"2026-05-29","current":-2.542561,"twenty":-2.153089,"median":-0.142947,"eighty":-0.029797,"marketCap":10021751},{"date":"2026-06-05","current":-2.146922,"twenty":-2.298196,"median":-0.143778,"eighty":-0.030189,"marketCap":8462302},{"date":"2026-06-12","current":-2.030558,"twenty":-2.274923,"median":-0.146804,"eighty":-0.030678,"marketCap":8003641},{"date":"2026-06-18","current":-1.797829,"twenty":-2.245584,"median":-0.147189,"eighty":-0.030678,"marketCap":7086318},{"date":"2026-06-26","current":-1.490225,"twenty":-2.170121,"median":-0.149241,"eighty":-0.030939,"marketCap":10336828},{"date":"2026-07-02","current":-1.710185,"twenty":-2.149389,"median":-0.15355,"eighty":-0.031298,"marketCap":11862560},{"date":"2026-07-10","current":-1.611203,"twenty":-2.115504,"median":-0.154425,"eighty":-0.031553,"marketCap":11175981},{"date":"2026-07-17","current":-1.655195,"twenty":-2.091114,"median":-0.156664,"eighty":-0.031788,"marketCap":11481127},{"date":"2026-07-24","current":-1.550714,"twenty":-2.088818,"median":-0.159435,"eighty":-0.032349,"marketCap":10756404},{"date":"2026-07-31","current":-1.847659,"twenty":-2.088818,"median":-0.16212,"eighty":-0.032649,"marketCap":12816142},{"date":"2026-08-07","current":-1.919146,"twenty":-2.070168,"median":-0.165065,"eighty":-0.033047,"marketCap":13312004},{"date":"2026-08-14","current":-1.957639,"twenty":-2.03754,"median":-0.169709,"eighty":-0.033798,"marketCap":13579007},{"date":"2026-08-21","current":-2.161101,"twenty":-2.088818,"median":-0.171634,"eighty":-0.034281,"marketCap":14990309}],"updateTime":1787449020316},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628789530","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:06 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2628789530","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628789530?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:06","pubTimestamp":1776452790,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 03:06 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nAQN2LV5DN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628834747","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2628834747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628834747?lang=en_us&edition=fundamental","pubTime":"2026-04-18 00:45","pubTimestamp":1776444351,"startTime":"0","endTime":"0","summary":"Critical Metals  said Friday that the Government of Greenland has approved the transfer of the remaining 50.5% stake in Tanbreez Mining Greenland, increasing the company's ownership to 92.5%.Shares surged 35% as intraday trading volume soared to over 57.2 million from a daily average of about 12.5 million.B. Riley raised its price target for Bandwidth's  shares to $27 from $20 while keeping the stock's buy rating.Shares jumped 9%, with intraday trading volume at over 333,000, compared with a daily average of about 410,000.Psyence Biomedical  acknowledged recent reports saying that the US administration is preparing an executive order to further evaluate the safety and therapeutic potential of ibogaine, a naturally occurring compound being studied for its potential in treating post-traumatic stress disorder, addiction, and other serious neurological and mental health conditions.Through its investment in PsyLabs, Psyence has established a position in the manufacturing of ibogaine and ibo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BAND","CRMU","PBM","BK4139","BK4089","CRML","CRMX","BK4168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628913201","title":"Psyence BioMed welcomes planned US executive order to evaluate ibogaine research","url":"https://stock-news.laohu8.com/highlight/detail?id=2628913201","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628913201?lang=en_us&edition=fundamental","pubTime":"2026-04-17 21:15","pubTimestamp":1776431723,"startTime":"0","endTime":"0","summary":"Psyence BioMed welcomed reports that U.S. administration is preparing an executive order to evaluate ibogaine safety and therapeutic potential.CEO Jody Aufrichtig backed structured, evidence-based research to clarify ibogaine safety, efficacy, and role in clinical care.Psyence BioMed flagged ibogaine’s Schedule I status in U.S., citing patient access through unregulated settings outside country.Company highlighted GMP-compliant ibogaine manufacturing capabilities through PsyLabs to support global clinical research.Psyence BioMed reiterated development of an ethically sourced supply chain in Africa to support standardized ibogaine availability as regulation evolves.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL3tpXRr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","PBM","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628098862","title":"Why Is Psyence Biomedical Stock (PBM) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2628098862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628098862?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:33","pubTimestamp":1776429199,"startTime":"0","endTime":"0","summary":"Psyence Biomedical stock was up on Friday after the company expanded its clinical trial network in Australia.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-psyence-biomedical-stock-pbm-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-psyence-biomedical-stock-pbm-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628203908","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2628203908","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628203908?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:31","pubTimestamp":1776425472,"startTime":"0","endTime":"0","summary":"Psyence Biomedical  shares were up 84% in Friday premarket activity, extending Thursday's rally.Texxon  stock was 60% higher, recovering from the previous session's loss.Autoliv  shares were up 9.4% after the company reported higher Q1 net sales.Ally Financial  shares were up 4.3% after the company posted higher Q1 adjusted earnings and revenue.JetBlue Airways  stock was 2.5% higher, a day after the company said it started daily seasonal flights connecting Boston and Barcelona, with one-way tickets priced starting at $349 for standard seating and $1,799 for premium cabins.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2242652126.USD","BK4588","LU2242646821.SGD","BK4104","BK4559","ALV","LU1668664300.SGD","LU0980610538.SGD","BK4124","BK4166","BK7095","LU1201861249.SGD","LU1791807156.HKD","ALLY","JBLU","BK4008","LU0106831901.USD","BK4500","BK4139","LU0648001328.SGD","LU0130102774.USD","NPT","LU0130517989.USD","LU0477156953.USD","BK4561","PBM","BK4585","ALV.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627212285","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:50 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2627212285","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627212285?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:50","pubTimestamp":1776354642,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:50 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nAQN2LUZRU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625944115","title":"Psyence Biomedical Ltd - Expands Australian Clinical Site Network to Five Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2625944115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625944115?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:16","pubTimestamp":1775654210,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40R19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625944112","title":"Psyence BioMed expands Australia clinical trial network to five sites for NPX-5 program","url":"https://stock-news.laohu8.com/highlight/detail?id=2625944112","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625944112?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:15","pubTimestamp":1775654154,"startTime":"0","endTime":"0","summary":"Psyence BioMed expanded Australian clinical site network to five sites from three to support NPX-5 clinical activities.Ramsay Health Care, NeuroCentrix added to strengthen recruitment, accelerate enrollment for Phase IIb trial.Phase IIb study evaluates natural psilocybin for Adjustment Disorder in cancer patients receiving palliative care.Trial currently runs at sites in Perth, Melbourne, with initial patient dosing starting in late 2025.Program supply uses GMP-compliant NPX-5 psilocybin capsules manufactured at PsyLabs GMP-controlled facility.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbwkCbW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK7113","PBM","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","RHC.AU","IE00BN0W2W23.USD","BK4139","BK4588","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624528365","title":"A Look At Cigna Group’s Valuation After PBM Reform Progress And New CEO Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2624528365","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624528365?lang=en_us&edition=fundamental","pubTime":"2026-04-02 07:28","pubTimestamp":1775086120,"startTime":"0","endTime":"0","summary":"Recent analyst commentary around pharmacy benefit manager reform, a rebate-free model and a leadership change has put Cigna Group (CI) back in focus for investors watching how regulatory shifts shape earnings visibility.\nSee our latest analysis for Cigna Group.\nThose regulatory updates and the CEO transition are playing out against a softer trading backdrop, with a 30 day share price return of an 8.09% decline and a 1 year total shareholder return of a 17.76% loss suggesting momentum has...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/172899-main-header/1756254126085","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/172899-main-header/1756254126085"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/a-look-at-cigna-groups-valuation-after-pbm-reform-progress-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-ci/cigna-group/news/a-look-at-cigna-groups-valuation-after-pbm-reform-progress-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z3B42.SGD","LU2065732104.USD","BK4139","LU1059921491.USD","CI","LU1261432733.SGD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU0868494617.USD","BK4585","BK4196","LU0289739699.SGD","BK4097","PRGS","IE0002270589.USD","PBM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622869076","title":"Mochi Finance founder offloads 550K CVX as fraud claims deepen across DeFi","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869076","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622869076?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:46","pubTimestamp":1774536390,"startTime":"0","endTime":"0","summary":"Mochi founder Azeem Ahmed sold 550K CVX from a Curve-linked stash as on-chain probes allege over $8M in diverted rewards and $54M in DeFi losses.Mochi Finance founder Azeem Ahmed sold about 550,285 CVX for roughly $946,000, pushing the token down more than 10%.The CVX stack traces back to a 2021 Curve pool drain that left liquidity providers with an estimated $54 million in losses.Beyond staking flows, investigators allege that about 2,198 ETH—worth roughly $6.67 million at the time—and $471,429 in USDC were drained from Mochi/ETH liquidity pools and never returned to depositors, while airdrops fr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/mochi-finance-founder-offloads-550k-cvx-as-fraud-claims-deepen-across-defi/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/mochi-finance-founder-offloads-550k-cvx-as-fraud-claims-deepen-across-defi/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["IE000M9KFDE8.USD","LU1074936037.SGD","LU0320765489.SGD","LU0234572021.USD","LU1116320737.USD","LU2129689431.USD","LU2129689514.USD","LU2381873111.SGD","LU0208291251.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0266512127.USD","BK4559","IE00B7SZLL34.SGD","BK4550","BK4570","LU0612318971.USD","LU1496350171.SGD","SG9999002521.SGD","IE00B2Q91V27.USD","IE00BGHQF524.EUR","LU2133065610.SGD","LU0640476718.USD","BK4139","LU0320765646.SGD","LU1066053197.SGD","LU1116320901.HKD","PBM","LU0612318385.USD","BK4566","LU1430597077.USD","BK4084","LU0256863811.USD","LU1496350502.SGD","LU0942090050.USD","BK4234","LU1929549753.HKD","CVX","SAFE","LU1280957306.USD","LU0070302665.USD","BK4534","LU0300736492.USD","LU0630314457.HKD","BK4581","BK4588","LU0788109394.HKD","LU0368265418.SGD","LU2129689605.HKD","IE00B3CCJ963.GBP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622835066","title":"Psyence Group; GoldCoast private placement raises $2.78 million on $0.85 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622835066","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622835066?lang=en_us&edition=fundamental","pubTime":"2026-03-26 14:24","pubTimestamp":1774506295,"startTime":"0","endTime":"0","summary":"Psyence reported that GoldCoast completed a non-brokered private placement of 3,280,140 common shares at CAD 0.85 per share.The second tranche raised gross proceeds of CAD 2.78 million.Including a previously completed brokered tranche of CAD 5.83 million, aggregate gross proceeds totaled CAD 8.6 million.The financing was completed in connection with GoldCoast’s proposed amalgamation with Psyence.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Group Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3HNsl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622001336","title":"Should FTC Insulin Settlement And PBM Lawsuit Shift How Investors View CVS Health’s (CVS) Risk-Reward Profile?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622001336","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622001336?lang=en_us&edition=fundamental","pubTime":"2026-03-26 02:14","pubTimestamp":1774462482,"startTime":"0","endTime":"0","summary":"CVS Health recently reached a proposed settlement with the Federal Trade Commission over insulin pricing practices in its Caremark pharmacy benefit manager unit, while also facing a new class action lawsuit alleging improper formulary-related fees. \nAt the same time, CVS Health’s board affirmed its quarterly US$0.665 dividend and added former Elevance Health CFO John E. Gallina as an audit committee financial expert, underscoring governance and capital-return priorities amid regulatory...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/93625-main-header/1756253484610"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/should-ftc-insulin-settlement-and-pbm-lawsuit-shift-how-inve","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-cvs/cvs-health/news/should-ftc-insulin-settlement-and-pbm-lawsuit-shift-how-inve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","LU0006061336.USD","AI","CVS.AU","BK4587","LU1571399168.USD","LU0070302665.USD","BK4585","BK4139","FTC","PBM","BK4504","BK4550","IE00B19Z3581.USD","LU0432979614.USD","LU0211331839.USD","BK4588","IE00BSNM7G36.USD","LU0061475181.USD","BK4543","LU0162691827.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","CVS","BK4528","BK4551","IE0002270589.USD","LU1983299246.USD","LU1699723380.USD","CHAT","ISBC","AGIX","IE00B7SZLL34.SGD","AIPO","AIYY","BK4023","LU0072461881.USD","BK4581","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4196","LU0208291251.USD","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620280915","title":"Psyence Group says GoldCoast raises CAD 5.83 million in financing tied to proposed amalgamation","url":"https://stock-news.laohu8.com/highlight/detail?id=2620280915","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620280915?lang=en_us&edition=fundamental","pubTime":"2026-03-18 15:20","pubTimestamp":1773818407,"startTime":"0","endTime":"0","summary":"Psyence has a definitive amalgamation agreement with GoldCoast, dated Nov. 21, 2025 and amended Feb. 24, 2026. GoldCoast completed a brokered private placement of 6,853,840 shares at CAD 0.85 per share for gross proceeds of CAD 5.83 million. GoldCoast expects to complete a non-brokered private placement at the same price in tranches over the next several weeks. The financing satisfied a condition precedent to the proposed amalgamation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Group Inc. published the original content used to generate this news brief on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL62lgvy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618294000","title":"Psyence BioMed Plans to Advance Vertically Integrated Platform and Product and Clinical Development Program, Targeting Phase IIb Trial Execution and Regulatory Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2618294000","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618294000?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:25","pubTimestamp":1773235523,"startTime":"0","endTime":"0","summary":"Psyence BioMed Plans to Advance Vertically Integrated Platform and Product and Clinical Development Program, Targeting Phase IIb Trial Execution and Regulatory Readiness. Psyence Biomedical Ltd. said it plans to continue executing its vertically integrated pharmaceutical platform and advance its product and clinical development program, including implementing a Phase IIb clinical trial on schedule while maintaining required regulatory and other consents. The company also indicated it aims to support long-term competitiveness and reduce strategy execution risk through operational and commercial readiness of its integrated model, and noted that a share consolidation may be implemented in the future, though timing is uncertain.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL25g3Vy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618169940","title":"Psyence Biomedical appoints Sashank Pillay to board after Seth Feuerstein resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2618169940","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618169940?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:15","pubTimestamp":1773234919,"startTime":"0","endTime":"0","summary":"Psyence BioMed said Seth Feuerstein resigned as a director effective Feb. 20, 2026. The company appointed Sashank Pillay to fill the board vacancy. Pillay previously served as a country manager and community and government relations liaison for governmentally licensed psilocybin cultivation and production facilities in Southern Africa.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL6LtrVn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU0314104364.USD","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","BK4585","BK4588","LU2210149790.SGD","PBM","BK4139","IE00BKPKM429.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618151940","title":"Corporate Update: Psyence Biomed Advances Vertically Integrated Pharmaceutical Platform Following Psylabs Export Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2618151940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618151940?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:15","pubTimestamp":1773234900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA7WZM0S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616268483","title":"BRIEF-Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616268483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616268483?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:15","pubTimestamp":1772547342,"startTime":"0","endTime":"0","summary":"BRIEF-Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical TrialMarch 3 (Reuters) - Psyence Biomedical Ltd PBM.O:PSYENCE BIOMED AN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUAPKD6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616832502","title":"Psyence Biomed Announces Export of Gmp-Manufactured Natural Psilocybin (Npx-5) to Australia for Ongoing Phase Iib Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616832502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616832502?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:15","pubTimestamp":1772547300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nTUAPKD6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616933331","title":"Psyence Biomedical Names Sashank Pillay to Board After Seth Feuerstein Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2616933331","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616933331?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:08","pubTimestamp":1772453298,"startTime":"0","endTime":"0","summary":"Psyence Biomedical Ltd. said director Seth Feuerstein resigned from its board effective Feb. 20, 2026. The company appointed Sashank Pillay to fill the vacancy, and he will serve on the audit, compensation, and nominating and corporate governance committees.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL7bdQS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613194127","title":"Psyence extends GoldCoast amalgamation deadline to May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613194127","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613194127?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:42","pubTimestamp":1771936974,"startTime":"0","endTime":"0","summary":"Psyence Group Inc. has signed an amending agreement with GoldCoast Resource Corp. and its subsidiary Psyence Therapeutics Corp. to extend the timeline for their proposed three-cornered amalgamation. The deadline to hold required shareholder meetings was pushed to April 30, 2026, and the outside date to complete the deal was extended to May 31, 2026. The amendment also lowers Psyence’s minimum cash condition at closing to C$250,000 from C$400,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Group Inc. published the original content used to generate this news brief on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLbSLjwn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}